Home renal therapy system and machine

US11819596B2 · kind B2 · utility

Assignees

• Baxter International Inc. · US
• Baxter Healthcare SA · CH

Inventors

• Neil Tiwari · Wood Dale, US
• Joshua James Miller · Wilmette, US
• Marc Steven Minkus · Bannockburn, US
• Matthew R. Muller · Lindenhurst, US
• Derek Wiebenson · Zürich, CH
• Douglas L. Wilkerson · Gurnee, US
• Timothy G. Robinson · Easton, US
• Anders Wellings · Newark, US
• Kathryn Louise Hansbro · Yeadon, US
• Borut Cizman · Highwood, US
• Brian S. Kunzeman · Grayslake, US
• Robin D. Cooper · Wauconda, US
• Timothy L. Kudelka · Lindenhurst, US
• Angelo A. Sarto · Franksville, US
• Steve Joseph Lindo · Chicago, US
• Jostein Baustad · Evanston, US
• Duston Mounts · The Colony, US
• Shafali Hill · Gurnee, US

Key dates

• Filing date: Feb 28, 2022
• Grant date: Nov 21, 2023
• Expiry date: Feb 28, 2042

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61M2205/50
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

A renal therapy system is disclosed. In an example, the renal therapy system includes a user interface device, such as a tablet computer. The renal therapy system also includes a renal therapy machine configured to perform a renal therapy. The renal therapy machine includes a data transfer interface configured to communicatively couple to the user interface device, a dialysis fluid pump, and a processor that operates a connectivity agent having an activated mode and a deactivated mode. When in the activated mode, the connectivity agent enables the processor to send data related to a performance of the renal therapy to a system hub. In the deactivated mode, the processor is prevented from sending the data to or receiving any data from the system hub. The user interface device is configured to receive data from and send data to the processor regardless of a status of the connectivity agent.